<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>18</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Efficacy and Safety of Bacterial-Based Cancer Therapies: A Meta-Analysis of Preclinical and Clinical Studies</title>
	<subject_fa>Infectious Diseases</subject_fa>
	<subject>Infectious Diseases</subject>
	<content_type_fa>متا آنالیز</content_type_fa>
	<content_type>Meta-analysis</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;line-height:2;&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Cancer remains a major global health burden, and while conventional treatments like chemotherapy and immunotherapy have improved outcomes, they are limited by resistance and adverse effects. Bacterial-based cancer therapies (BBCTs) offer a promising alternative due to their tumor-targeting ability, immune modulation, and potential as therapeutic vectors.&lt;br&gt;
&lt;strong&gt;Objective: &lt;/strong&gt;This meta-analysis evaluates the efficacy and safety of BBCTs by analyzing tumor growth inhibition (TGI%) in preclinical models and progression-free survival (PFS), overall survival (OS), and optimal response rate (ORR) in clinical studies.&lt;br&gt;
&lt;strong&gt;Methods:&lt;/strong&gt; &amp;nbsp;A systematic search of PubMed, Google Scholar, and Cochrane Library was conducted for relevant studies. Data on treatment efficacy and adverse events were extracted and statistically analyzed.&lt;br&gt;
&lt;strong&gt;Results: &lt;/strong&gt;BBCTs showed significant tumor suppression and survival benefits over controls. PFS consistently demonstrated tumor growth delay, and some OS values extended beyond 35 units, suggesting long-term benefit. However, variability in outcomes was noted, influenced by bacterial strain, tumor type, and immune response. Safety concerns, including toxicity and immune-related effects, were also observed.&lt;br&gt;
&lt;strong&gt;Conclusion: &lt;/strong&gt;BBCTs show strong therapeutic promise, but further clinical validation is needed to improve delivery, consistency, and safety. Personalized, translational research is key to bridging preclinical findings with clinical application.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Bacteria-based Carcinoma, Tumor, Therapeutics, Anticancer</keyword>
	<start_page>102</start_page>
	<end_page>113</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-2044-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Prithpal</first_name>
	<middle_name></middle_name>
	<last_name>Singh Matreja</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460013160</code>
	<orcid>100319475328460013160</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Teerthanker Mahaveer Medical College and Research Centre, Teerthanker Mahaveer University, Moradabad, UP, India.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ajay</first_name>
	<middle_name></middle_name>
	<last_name>Kumar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460013161</code>
	<orcid>100319475328460013161</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Teerthanker Mahaveer Medical College and Research Centre, Teerthanker Mahaveer University, Moradabad, UP, India.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Vinod</first_name>
	<middle_name></middle_name>
	<last_name>Kumar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460013162</code>
	<orcid>100319475328460013162</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Teerthanker Mahaveer Medical College and Research Centre, Teerthanker Mahaveer University, Moradabad, UP, India.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Sudhir</first_name>
	<middle_name></middle_name>
	<last_name>Singh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>singhdrsudhir4@gmail.com</email>
	<code>100319475328460013163</code>
	<orcid>100319475328460013163</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Teerthanker Mahaveer Medical College and Research Centre, Teerthanker Mahaveer University, Moradabad, UP, India.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
